Randomized, Placebo-Controlled, Ascending Multiple Dose Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-707035 in HIV-1 Infected Subjects.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 26 Apr 2012
At a glance
- Drugs BMS 707035 (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 22 Nov 2006 New trial record.